Future Market Insights (FMI), a leader in market intelligence and consulting services, has released a comprehensive report forecasting impressive growth for the global aspiration and biopsy needles market. The report indicates that the market, valued at USD 777.29 million in 2023, is projected to nearly double in the next decade, reaching USD 1,405.2 million by 2033. This growth is supported by a steady Compound Annual Growth Rate (CAGR) of 6.1% throughout the forecast period.
The rising preference for minimally invasive procedures in healthcare is a key factor driving this market expansion. Aspiration and biopsy needles play a vital role in these procedures, delivering notable benefits such as reduced patient discomfort, faster recovery times, and better overall outcomes. This combination of advantages has contributed to a growing adoption rate among healthcare providers and patients, fostering demand for advanced medical solutions.
“The global aspiration and biopsy needles market is poised for substantial growth over the coming decade,” stated a representative from Future Market Insights. “Technological advancements in medical devices, along with rising investments in healthcare, are expected to further accelerate market dynamics, creating a favorable environment for innovation.”
The report also provides detailed geographical insights, with North America and Europe emerging as key revenue-generating regions. These markets benefit from well-established healthcare infrastructures, high adoption rates of cutting-edge medical technologies, and an increasing prevalence of chronic diseases that necessitate biopsy procedures.
As the aspiration and biopsy needles market continues its growth trajectory, FMI advises stakeholders to capitalize on emerging technological innovations and market opportunities to stay competitive. Committed to delivering actionable insights and strategic recommendations, Future Market Insights supports healthcare industry stakeholders in making informed, data-driven decisions.
Top Highlights from the FMI’s Analysis of the Aspiration & Biopsy Needles Market:
- North America represented 34% market share in 2022. The regional market is projected to lead the market over the upcoming years. This can be attributed to the strong presence of market participants in the region. The introduction of new product lines and higher accessibility to treatment facilities in North America is pushing the market growth.
- Europe demonstrated a 26% overall market share. The industry growth has been catalyzed by many research and development activities and studies.
- Hospitals are expected to capture a significant portion of the market. In 2022, the segment acquired 46% of the market. Building upon the prior growth, the future market scope of the segment looks bright.
- The core biopsy needles segment attained a 58.60% market share in 2022. The demand graph of this product segment is projected to show an upward trend.
- India is expected to grow at lightning-bolt speed in the coming years. FMI has predicted an 8.3% CAGR for India from 2023 to 2033.
High Demand for Market Insights: Discover Comprehensive Trends in Our Full Report!
Keeping Abreast with the Market Ongoings: Market News
- Micro-Tech Endoscopy strives to develop high-quality products for endoscopic diagnosis. In October 2021, the company released an improved version of EUS needles, such as Trident FNB and Areus FNA.
- NeoDynamics AB is a MedTech company, which is devoted to enhancing breast cancer treatment and diagnosis. The company’s patent for a biopsy needle got approved in the United States, in August 2021, to be used in NeoNavia FlexiPulse probe.
- In January 2019, IZI Medical Products procured the needle product line of soft tissue biopsy and breast localization of Cook Medical.
Key Players in the Market:
- Merit Medical Systems
- Cook Group Incorporated
- Olympus Corporation
- Medtronic PLC
- Argon Medical Devices Inc.
- Boston Scientific Corporation
- Cardinal Health Inc.
- Conmed Corporation
- Inrad Inc.
Key Segments:
By Product Type:
- Biopsy Needles
- Aspiration Needles
By Application:
- Tumor/Cancer Applications
- Wound Applications
- Other Applications
By Procedure:
- Image-guided Procedures
- Non-image-guided Procedures
By End User:
- Hospitals & Surgical Centers
- Diagnostic Clinics & Pathology Laboratories
- Ambulatory Care Centers
- Research & Academic Institutes
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube